Eyenuk AI Techlology Selected for Diabetic Eye Testing in Vietnam Supported by The Fred Hollows Foundation

Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, announced that its EyeArt AI system for diabetic eye testing has been chosen for deployment in 4 hospitals in Binh Dinh Province, Vietnam. The project is funded by The Fred Hollows Foundation. "We are excited to implement the EyeArt AI system to expand our capabilities in detection and treatment of diabetic retinopathy. It will help us reach our goal to protect the vision of approximately six million people with diabetes living in Vietnam," said Pham Quoc Anh, Vietnam Country Manager for The Fred Hollows Foundation. "This important project will help us continue the work first started by Professor Fred Hollows 29 years ago, fulfilling his vision to bring equitable eye health for all."